speb/financial-data huggingface dataset:
YB cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: -10658000.00
YB cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
YB cash_flow (annual, 2024-12-31) — Purchase Of Investment: -3896231000.00
YB cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -1743985000.00
YB cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3341000.00
YB cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -335000.00
YB balance_sheet (annual, 2024-12-31) — Receivables: 260518000.00
YB balance_sheet (quarterly, 2024-12-31) — Receivables: 260518000.00
YB balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -615000.00
YB balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -615000.00
YB income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 333826000.00
YB income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 127024000.00
YB income_statement (annual, 2024-12-31) — Reconciled Depreciation: 14948000.00
YB income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 3868000.00
YB income_statement (annual, 2024-12-31) — Research And Development: 231041000.00
YB income_statement (quarterly, 2024-12-31) — Research And Development: 80320000.00
YB balance_sheet (annual, 2024-12-31) — Restricted Cash: 15000000.00
YB balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 15000000.00
YB balance_sheet (annual, 2024-12-31) — Retained Earnings: -1932128000.00
YB balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -1932128000.00
YB income_statement (annual, 2024-12-31) — Salaries And Wages: 240275000.00
YB income_statement (quarterly, 2024-12-31) — Salaries And Wages: 103953000.00
YB cash_flow (annual, 2024-12-31) — Sale Of Investment: 3741939000.00
YB cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 1590884000.00
YB cash_flow (annual, 2024-12-31) — Sale Of PPE: 63000.00
YB cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
YB income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1743121000.00
YB income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 370009000.00
YB income_statement (annual, 2024-12-31) — Selling General And Administration: 1788272000.00
YB income_statement (quarterly, 2024-12-31) — Selling General And Administration: 372699000.00
YB balance_sheet (annual, 2024-12-31) — Share Issued: 270481206.00
YB balance_sheet (quarterly, 2024-12-31) — Share Issued: 270481206.00
YB cash_flow (annual, 2024-12-31) — Stock Based Compensation: 64017000.00
YB cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 20733000.00
YB balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1787085000.00
YB balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1787085000.00
YB balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1691846000.00
YB balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -1691846000.00
YB income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 193406.23
YB income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 187965.56
YB income_statement (annual, 2024-12-31) — Tax Provision: 25568000.00
YB income_statement (quarterly, 2024-12-31) — Tax Provision: 9035000.00
YB income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.03
YB income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.03
YB balance_sheet (annual, 2024-12-31) — Taxes Receivable: 175000.00
YB balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 175000.00
YB balance_sheet (annual, 2024-12-31) — Total Assets: 2779640000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Assets: 2779640000.00
YB balance_sheet (annual, 2024-12-31) — Total Capitalization: 1787085000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 1787085000.00
YB balance_sheet (annual, 2024-12-31) — Total Debt: 19161000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Debt: 19161000.00
YB balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1787085000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1787085000.00
YB income_statement (annual, 2024-12-31) — Total Expenses: 2425919000.00
YB income_statement (quarterly, 2024-12-31) — Total Expenses: 599548000.00
YB balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 992555000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 992555000.00
YB balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 106827000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 106827000.00
YB balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 51744000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 51744000.00
YB balance_sheet (annual, 2024-12-31) — Total Tax Payable: 51359000.00
YB balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 51359000.00
YB income_statement (annual, 2024-12-31) — Total Unusual Items: 6743000.00
YB income_statement (quarterly, 2024-12-31) — Total Unusual Items: 6269000.00
YB income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6743000.00
YB income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6269000.00
YB cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -1544000.00
YB balance_sheet (annual, 2024-12-31) — Working Capital: 1732002000.00
YB balance_sheet (quarterly, 2024-12-31) — Working Capital: 1732002000.00
YB income_statement (quarterly, 2025-03-31) — +Operating Expense: 680644000.00
YB income_statement (quarterly, 2025-03-31) — +Total Revenue: 970056000.00
YB balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 20730000.00
YB balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 332586000.00
YB balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 215743000.00
YB income_statement (quarterly, 2025-03-31) — Basic Average Shares: 45080201.00
YB income_statement (quarterly, 2025-03-31) — Basic EPS: 7.02
YB balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 15845000.00
YB balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3399367000.00
YB balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2236013000.00
YB balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2751721000.00
YB balance_sheet (quarterly, 2025-03-31) — Common Stock: 71000.00
YB balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -1300346000.00
YB income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 44756000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 758236000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Assets: 3144298000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 13548000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 13548000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 95405000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 95405000.00
YB balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1098518000.00
YB income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 45080201.00
YB income_statement (quarterly, 2025-03-31) — Diluted EPS: 7.02
YB income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 316688000.00
YB income_statement (quarterly, 2025-03-31) — EBIT: 289412000.00
YB income_statement (quarterly, 2025-03-31) — EBITDA: 289412000.00
YB income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 6741000.00
YB balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 99280000.00
YB income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 66640000.00
YB balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 58026000.00
YB balance_sheet (quarterly, 2025-03-31) — Gross PPE: 21258000.00
YB income_statement (quarterly, 2025-03-31) — Gross Profit: 925300000.00
YB income_statement (quarterly, 2025-03-31) — Interest Income: 5228000.00
YB income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5228000.00
YB balance_sheet (quarterly, 2025-03-31) — Invested Capital: -1300346000.00
YB balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2297000.00
YB balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2297000.00
YB income_statement (quarterly, 2025-03-31) — Net Income: 295102000.00
YB income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 316688000.00
YB income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 295102000.00
YB income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 295102000.00
YB income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 295102000.00
YB income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 295102000.00
YB income_statement (quarterly, 2025-03-31) — Net Interest Income: 5228000.00
YB income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 5228000.00
YB balance_sheet (quarterly, 2025-03-31) — Net PPE: 21258000.00
YB balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2040924000.00
YB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 7045000.00
YB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 48473000.00
YB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 7045000.00
YB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 48473000.00
YB income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 282671000.00
YB income_statement (quarterly, 2025-03-31) — Normalized Income: 288511043.20
YB income_statement (quarterly, 2025-03-31) — Operating Income: 289412000.00
YB income_statement (quarterly, 2025-03-31) — Operating Revenue: 970056000.00
YB balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 270481206.00
YB balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 44991000.00
YB balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 99280000.00
YB income_statement (quarterly, 2025-03-31) — Other Gand A: 66640000.00
YB income_statement (quarterly, 2025-03-31) — Other Income Expense: 7180000.00
YB balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 17611000.00
YB income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 439000.00
YB income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 44756000.00
YB balance_sheet (quarterly, 2025-03-31) — Other Payable: 159426000.00
YB balance_sheet (quarterly, 2025-03-31) — Other Properties: 21258000.00
YB balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 515708000.00
YB income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: -21586000.00
YB balance_sheet (quarterly, 2025-03-31) — Payables: 231329000.00
YB balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 989565000.00
YB balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 3399296000.00
YB balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 3399296000.00
YB balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 3399296000.00
YB income_statement (quarterly, 2025-03-31) — Pretax Income: 301820000.00
YB balance_sheet (quarterly, 2025-03-31) — Receivables: 332586000.00
YB income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 44756000.00
YB income_statement (quarterly, 2025-03-31) — Research And Development: 76098000.00
YB balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 15000000.00
YB balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1615440000.00
YB income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 493150000.00
YB income_statement (quarterly, 2025-03-31) — Selling General And Administration: 559790000.00
YB balance_sheet (quarterly, 2025-03-31) — Share Issued: 270481206.00
YB balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2098950000.00
YB balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1358372000.00
YB income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 150043.20
YB income_statement (quarterly, 2025-03-31) — Tax Provision: 6718000.00
YB income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.02
YB balance_sheet (quarterly, 2025-03-31) — Total Assets: 3248238000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2098950000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Debt: 15845000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2098950000.00
YB income_statement (quarterly, 2025-03-31) — Total Expenses: 680644000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1149288000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 103940000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 50770000.00
YB balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 51173000.00
YB income_statement (quarterly, 2025-03-31) — Total Unusual Items: 6741000.00
YB income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 6741000.00
YB balance_sheet (quarterly, 2025-03-31) — Working Capital: 2045780000.00
YB income_statement (quarterly, 2025-06-30) — +Operating Expense: 772194000.00
YB income_statement (quarterly, 2025-06-30) — +Total Revenue: 1069926000.00
YB balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 18737000.00
YB balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 349326000.00
YB balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3141956000.00
YB income_statement (quarterly, 2025-06-30) — Basic Average Shares: 36000664.00
YB income_statement (quarterly, 2025-06-30) — Basic EPS: 27.36
YB balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 15118000.00
YB balance_sheet (quarterly, 2025-06-30) — Capital Stock: 189000.00
YB balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1319407000.00
YB balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 3403704000.00
YB balance_sheet (quarterly, 2025-06-30) — Common Stock: 189000.00
YB balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2608155000.00
YB income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 40900000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 956960000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Assets: 3798827000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 13612000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 13612000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 93281000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 93281000.00
YB balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1236628000.00
YB income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 47013461.00
YB income_statement (quarterly, 2025-06-30) — Diluted EPS: 6.48
YB income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 983900000.00
YB balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 4300000.00
YB income_statement (quarterly, 2025-06-30) — EBIT: 297732000.00
YB income_statement (quarterly, 2025-06-30) — EBITDA: 297732000.00
YB income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 8318000.00
YB balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 97550000.00
YB income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 47496000.00
YB balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 58002000.00
YB balance_sheet (quarterly, 2025-06-30) — Gross PPE: 22097000.00
YB income_statement (quarterly, 2025-06-30) — Gross Profit: 1029026000.00
YB income_statement (quarterly, 2025-06-30) — Interest Income: 5941000.00
YB income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5941000.00
YB balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2608155000.00
YB balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1506000.00
YB balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1506000.00
YB income_statement (quarterly, 2025-06-30) — Net Income: 304691000.00
YB income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 983900000.00
YB income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 304691000.00
YB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 304691000.00
YB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 304691000.00
YB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 304691000.00
YB income_statement (quarterly, 2025-06-30) — Net Interest Income: 5941000.00
YB income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 5941000.00
YB balance_sheet (quarterly, 2025-06-30) — Net PPE: 22097000.00
YB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2550153000.00
YB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 8493000.00
YB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 58733000.00
YB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 8493000.00
YB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 58733000.00
YB income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 289414000.00
YB income_statement (quarterly, 2025-06-30) — Normalized Income: 296665833.72
YB income_statement (quarterly, 2025-06-30) — Operating Income: 297732000.00
YB income_statement (quarterly, 2025-06-30) — Operating Revenue: 1069926000.00
YB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 276481206.00
YB balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 26497000.00
YB balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 97550000.00
YB income_statement (quarterly, 2025-06-30) — Other Gand A: 47496000.00
YB income_statement (quarterly, 2025-06-30) — Other Income Expense: 12136000.00
YB balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 17603000.00
YB income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3818000.00
YB income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 40900000.00
YB balance_sheet (quarterly, 2025-06-30) — Other Payable: 120473000.00
YB balance_sheet (quarterly, 2025-06-30) — Other Properties: 22097000.00
YB balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2084297000.00
YB income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: -679209000.00
YB balance_sheet (quarterly, 2025-06-30) — Payables: 172775000.00
YB balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1129735000.00
YB balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 0.00
YB balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
YB income_statement (quarterly, 2025-06-30) — Pretax Income: 315809000.00
YB balance_sheet (quarterly, 2025-06-30) — Receivables: 353626000.00
YB income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 40900000.00
YB income_statement (quarterly, 2025-06-30) — Research And Development: 81723000.00
YB balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 15000000.00
YB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -631540000.00
YB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 602075000.00
YB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 649571000.00
YB balance_sheet (quarterly, 2025-06-30) — Share Issued: 276481206.00
YB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2608155000.00
YB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2550153000.00
YB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 292833.72
YB income_statement (quarterly, 2025-06-30) — Tax Provision: 11118000.00
YB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.04
YB balance_sheet (quarterly, 2025-06-30) — Total Assets: 3905022000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2608155000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Debt: 15118000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2608155000.00
YB income_statement (quarterly, 2025-06-30) — Total Expenses: 772194000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1296867000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 106195000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 60239000.00
YB balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 33565000.00
YB income_statement (quarterly, 2025-06-30) — Total Unusual Items: 8318000.00
YB income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 8318000.00
YB balance_sheet (quarterly, 2025-06-30) — Working Capital: 2562199000.00
YB income_statement (quarterly, 2025-09-30) — +Operating Expense: 803365000.00
YB income_statement (quarterly, 2025-09-30) — +Total Revenue: 1157903000.00
YB balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 14833000.00
YB balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 372827000.00
YB balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3162056000.00
YB balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 52166000.00
YB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 45007257.00
YB income_statement (quarterly, 2025-09-30) — Basic EPS: 8.22
YB balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11557000.00
YB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 189000.00
YB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 477568000.00
YB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3682813000.00
YB balance_sheet (quarterly, 2025-09-30) — Common Stock: 189000.00
YB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2995589000.00
YB income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 45066000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 851623000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Assets: 4097153000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 10273000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 10273000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 97166000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 97166000.00
YB balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1203916000.00
YB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 48301977.00
YB income_statement (quarterly, 2025-09-30) — Diluted EPS: 7.68
YB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 370364000.00
YB income_statement (quarterly, 2025-09-30) — EBIT: 354538000.00
YB income_statement (quarterly, 2025-09-30) — EBITDA: 354538000.00
YB income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 12977000.00
YB balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 94521000.00
YB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 93147000.00
YB balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 65033000.00
YB balance_sheet (quarterly, 2025-09-30) — Gross PPE: 18210000.00
YB income_statement (quarterly, 2025-09-30) — Gross Profit: 1112837000.00
YB income_statement (quarterly, 2025-09-30) — Interest Income: 5862000.00
YB income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 5862000.00
YB balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2995589000.00
YB balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 52166000.00
YB balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 52166000.00
YB balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1284000.00
YB balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1284000.00
YB income_statement (quarterly, 2025-09-30) — Net Income: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 370364000.00
YB income_statement (quarterly, 2025-09-30) — Net Interest Income: 5862000.00
YB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 5862000.00
YB balance_sheet (quarterly, 2025-09-30) — Net PPE: 18210000.00
YB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2930556000.00
YB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 11731000.00
YB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 62099000.00
YB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 11731000.00
YB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 62099000.00
YB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 341561000.00
YB income_statement (quarterly, 2025-09-30) — Normalized Income: 357658191.10
YB income_statement (quarterly, 2025-09-30) — Operating Income: 354538000.00
YB income_statement (quarterly, 2025-09-30) — Operating Revenue: 1157903000.00
YB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 276481206.00
YB balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 26513000.00
YB balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 94521000.00
YB income_statement (quarterly, 2025-09-30) — Other Gand A: 93147000.00
YB income_statement (quarterly, 2025-09-30) — Other Income Expense: 17869000.00
YB balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 18595000.00
YB income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4892000.00
YB income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 45066000.00
YB balance_sheet (quarterly, 2025-09-30) — Other Payable: 186094000.00
YB balance_sheet (quarterly, 2025-09-30) — Other Properties: 18210000.00
YB balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3205245000.00
YB income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
YB balance_sheet (quarterly, 2025-09-30) — Payables: 244854000.00
YB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1096477000.00
YB balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
YB balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
YB income_statement (quarterly, 2025-09-30) — Pretax Income: 378269000.00
YB balance_sheet (quarterly, 2025-09-30) — Receivables: 372827000.00
YB income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 45066000.00
YB income_statement (quarterly, 2025-09-30) — Research And Development: 95560000.00
YB balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 15000000.00
YB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -261177000.00
YB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 569592000.00
YB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 662739000.00
YB balance_sheet (quarterly, 2025-09-30) — Share Issued: 276481206.00
YB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2995589000.00
YB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2930556000.00
YB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 271191.10
YB income_statement (quarterly, 2025-09-30) — Tax Provision: 7905000.00
YB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.02
YB balance_sheet (quarterly, 2025-09-30) — Total Assets: 4262888000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2995589000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Debt: 11557000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2995589000.00
YB income_statement (quarterly, 2025-09-30) — Total Expenses: 803365000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1267299000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 165735000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 63383000.00
YB balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 43927000.00
YB income_statement (quarterly, 2025-09-30) — Total Unusual Items: 12977000.00
YB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 12977000.00
YB balance_sheet (quarterly, 2025-09-30) — Working Capital: 2893237000.00
YB income_statement (annual, 2025-12-31) — +Operating Expense: 2645433000.00
YB income_statement (quarterly, 2025-12-31) — +Operating Expense: 389230000.00
YB income_statement (annual, 2025-12-31) — +Total Revenue: 4373153000.00
YB income_statement (quarterly, 2025-12-31) — +Total Revenue: 1175268000.00
YB balance_sheet (annual, 2025-12-31) — Accounts Payable: 17378000.00
YB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17378000.00
YB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 441414000.00
YB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 441414000.00
YB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 3179602000.00
YB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3179602000.00
YB balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1706000.00
YB balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1706000.00
YB balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 52492000.00
YB balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 52492000.00
YB income_statement (annual, 2025-12-31) — Average Dilution Earnings: -700795000.00
YB income_statement (annual, 2025-12-31) — Basic Average Shares: 36041691.00
YB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 45032155.00
YB income_statement (annual, 2025-12-31) — Basic EPS: 55.74
YB income_statement (quarterly, 2025-12-31) — Basic EPS: 7.50
YB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1919674000.00
YB cash_flow (annual, 2025-12-31) — Capital Expenditure: -19040000.00
YB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 7923000.00
YB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 7923000.00
YB balance_sheet (annual, 2025-12-31) — Capital Stock: 190000.00
YB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 190000.00
YB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 860455000.00
YB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 860455000.00
YB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3963333000.00
YB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3963333000.00
YB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 196844000.00
YB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2722879000.00
YB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1495138000.00
YB cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
YB cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
YB cash_flow (annual, 2025-12-31) — Change In Account Payable: 6702000.00
YB cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 191129000.00
YB cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -8107000.00
YB cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -179000.00
YB cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -13805000.00
YB cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -54108000.00
YB cash_flow (annual, 2025-12-31) — Change In Payable: 67944000.00
YB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 259073000.00
YB cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 34895000.00
YB cash_flow (annual, 2025-12-31) — Change In Receivables: -179268000.00
YB cash_flow (annual, 2025-12-31) — Change In Tax Payable: -8107000.00
YB cash_flow (annual, 2025-12-31) — Change In Working Capital: 46608000.00
YB cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -179268000.00
YB cash_flow (annual, 2025-12-31) — Changes In Cash: -1030897000.00
YB balance_sheet (annual, 2025-12-31) — Common Stock: 190000.00
YB balance_sheet (quarterly, 2025-12-31) — Common Stock: 190000.00
YB balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3346295000.00
YB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3346295000.00
YB cash_flow (annual, 2025-12-31) — Common Stock Issuance: 204880000.00
YB income_statement (annual, 2025-12-31) — Cost Of Revenue: 391140000.00
YB balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 35991000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 35991000.00
YB balance_sheet (annual, 2025-12-31) — Current Assets: 4458040000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Assets: 4458040000.00
YB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 7077000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 7077000.00
YB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 7077000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 7077000.00
YB balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 63541000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 63541000.00
YB balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 63541000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 63541000.00
YB balance_sheet (annual, 2025-12-31) — Current Liabilities: 1138726000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1138726000.00
YB balance_sheet (annual, 2025-12-31) — Current Provisions: 77878000.00
YB balance_sheet (quarterly, 2025-12-31) — Current Provisions: 77878000.00
YB cash_flow (annual, 2025-12-31) — Deferred Income Tax: 97127000.00
YB cash_flow (annual, 2025-12-31) — Deferred Tax: 97127000.00
YB cash_flow (annual, 2025-12-31) — Depreciation: 17675000.00
YB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 17675000.00
YB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 17675000.00
YB income_statement (annual, 2025-12-31) — Diluted Average Shares: 47650402.00
YB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 48460150.00
YB income_statement (annual, 2025-12-31) — Diluted EPS: 27.42
YB income_statement (quarterly, 2025-12-31) — Diluted EPS: 6.96
YB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -363412000.00
YB income_statement (annual, 2025-12-31) — EBIT: 1336580000.00
YB income_statement (quarterly, 2025-12-31) — EBIT: 394898000.00
YB income_statement (annual, 2025-12-31) — EBITDA: 1354255000.00
YB income_statement (quarterly, 2025-12-31) — EBITDA: 394898000.00
YB cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -4797000.00
YB cash_flow (annual, 2025-12-31) — End Cash Position: 883980000.00
YB cash_flow (annual, 2025-12-31) — Financing Cash Flow: 196844000.00
YB cash_flow (annual, 2025-12-31) — Free Cash Flow: 1476098000.00
YB income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 40951000.00
YB income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 12915000.00
YB balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 239354000.00
YB balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 239354000.00
YB income_statement (annual, 2025-12-31) — General And Administrative Expense: 64949000.00
YB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -142334000.00
YB balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 64553000.00
YB balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 64553000.00
YB balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 443120000.00
YB balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 443120000.00
YB balance_sheet (annual, 2025-12-31) — Gross PPE: 22350000.00
YB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 22350000.00
YB income_statement (annual, 2025-12-31) — Gross Profit: 3982013000.00
YB cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 657000.00
YB income_statement (annual, 2025-12-31) — Interest Income: 22092000.00
YB income_statement (quarterly, 2025-12-31) — Interest Income: 5061000.00
YB income_statement (annual, 2025-12-31) — Interest Income Non Operating: 22092000.00
YB income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 5061000.00
YB balance_sheet (annual, 2025-12-31) — Invested Capital: 3346295000.00
YB balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3346295000.00
YB cash_flow (annual, 2025-12-31) — Investing Cash Flow: -2722879000.00
YB balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 52492000.00
YB balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 52492000.00
YB balance_sheet (annual, 2025-12-31) — Investments And Advances: 52492000.00
YB balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 52492000.00
YB cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 204880000.00
YB balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 846000.00
YB balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 846000.00
YB balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 846000.00
YB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 846000.00
YB cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -6900000.00
YB cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 204880000.00
YB income_statement (annual, 2025-12-31) — Net Income: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Net Income: 337383000.00
YB income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2008335000.00
YB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 337383000.00
YB income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 337383000.00
YB income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
YB income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 337383000.00
YB income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 337383000.00
YB cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1307540000.00
YB income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1307540000.00
YB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 337383000.00
YB income_statement (annual, 2025-12-31) — Net Interest Income: 22092000.00
YB income_statement (quarterly, 2025-12-31) — Net Interest Income: 5061000.00
YB cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2697155000.00
YB income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 22092000.00
YB income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 5061000.00
YB cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -8062000.00
YB balance_sheet (annual, 2025-12-31) — Net PPE: 22350000.00
YB balance_sheet (quarterly, 2025-12-31) — Net PPE: 22350000.00
YB cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18824000.00
YB balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3281742000.00
YB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3281742000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 33337000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 33337000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 169701000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 169701000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 33337000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 33337000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 169701000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 169701000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 15607000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 15607000.00
YB balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 8927000.00
YB balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 8927000.00
YB income_statement (annual, 2025-12-31) — Normalized EBITDA: 1313304000.00
YB income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 381983000.00
YB income_statement (annual, 2025-12-31) — Normalized Income: 1269537472.00
YB income_statement (quarterly, 2025-12-31) — Normalized Income: 326827854.10
YB cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1495138000.00
YB income_statement (annual, 2025-12-31) — Operating Income: 1336580000.00
YB income_statement (quarterly, 2025-12-31) — Operating Income: 394898000.00
YB income_statement (annual, 2025-12-31) — Operating Revenue: 4373153000.00
YB income_statement (quarterly, 2025-12-31) — Operating Revenue: 1175268000.00
YB balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 276481206.00
YB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 276481206.00
YB balance_sheet (annual, 2025-12-31) — Other Current Assets: 629000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 629000.00
YB balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 239354000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 239354000.00
YB income_statement (annual, 2025-12-31) — Other Gand A: 64949000.00
YB income_statement (quarterly, 2025-12-31) — Other Gand A: -142334000.00
YB income_statement (annual, 2025-12-31) — Other Income Expense: 50039000.00
YB income_statement (quarterly, 2025-12-31) — Other Income Expense: 12854000.00
YB balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 64553000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 64553000.00
YB cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1931000.00
YB balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 262000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 262000.00
YB income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 9088000.00
YB income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -61000.00
YB income_statement (annual, 2025-12-31) — Other Operating Expenses: 56538000.00
YB income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -74184000.00
YB balance_sheet (annual, 2025-12-31) — Other Payable: 893586000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Payable: 893586000.00
YB balance_sheet (annual, 2025-12-31) — Other Properties: 22350000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Properties: 22350000.00
YB balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 3102878000.00
YB balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 3102878000.00
YB income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: -700795000.00
YB income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
YB balance_sheet (annual, 2025-12-31) — Payables: 954239000.00
YB balance_sheet (quarterly, 2025-12-31) — Payables: 954239000.00
YB balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 990230000.00
YB balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 990230000.00
YB balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
YB balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
YB balance_sheet (annual, 2025-12-31) — Prepaid Assets: 28270000.00
YB balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 28270000.00
YB income_statement (annual, 2025-12-31) — Pretax Income: 1408711000.00
YB income_statement (quarterly, 2025-12-31) — Pretax Income: 412813000.00
YB cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 26000.00
YB cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -1003000.00
YB cash_flow (annual, 2025-12-31) — Purchase Of Business: -6900000.00
YB cash_flow (annual, 2025-12-31) — Purchase Of Investment: -10383987000.00
YB cash_flow (annual, 2025-12-31) — Purchase Of PPE: -19040000.00
YB balance_sheet (annual, 2025-12-31) — Receivables: 442283000.00
YB balance_sheet (quarterly, 2025-12-31) — Receivables: 442283000.00
YB balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -823000.00
YB balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -823000.00
YB income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 391140000.00
YB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 17675000.00
YB income_statement (annual, 2025-12-31) — Research And Development: 365113000.00
YB income_statement (quarterly, 2025-12-31) — Research And Development: 111732000.00
YB balance_sheet (annual, 2025-12-31) — Restricted Cash: 23525000.00
YB balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 23525000.00
YB balance_sheet (annual, 2025-12-31) — Retained Earnings: -72851000.00
YB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -72851000.00
YB cash_flow (annual, 2025-12-31) — Sale Of Investment: 7686832000.00
YB cash_flow (annual, 2025-12-31) — Sale Of PPE: 216000.00
YB income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 2158833000.00
YB income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 494016000.00
YB income_statement (annual, 2025-12-31) — Selling General And Administration: 2223782000.00
YB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 351682000.00
YB balance_sheet (annual, 2025-12-31) — Share Issued: 276481206.00
YB balance_sheet (quarterly, 2025-12-31) — Share Issued: 276481206.00
YB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 74319000.00
YB balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3346295000.00
YB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3346295000.00
YB balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3281742000.00
YB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3281742000.00
YB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 2948472.00
YB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 2359854.10
YB income_statement (annual, 2025-12-31) — Tax Provision: 101171000.00
YB income_statement (quarterly, 2025-12-31) — Tax Provision: 75430000.00
YB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.07
YB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18